Immunomodulatory Therapy With Thymopentin and Indomethacin
Authors:
- Andreas MarkewitzAMAndreas Markewitz
- Dietmar FuchsDFDietmar Fuchs
- Stefan LangSLStefan Lang
- Susanne ZariusSZSusanne Zarius
- Friedrich-Wilhelm SchildbergFSFriedrich-Wilhelm Schildberg
- Helmut WachterHWHelmut Wachter
- Bruno ReichartBRBruno Reichart
- 1 September 1991
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 214 (3) , 264-275
Abstract
Prostaglandin E2 (PGE2)-mediated monocyte (Mos) suppressor activity and inadequate T-helper cell function represent the mechanistic keystones of trauma-induced impairment of cell-mediated immunity (CMI). In a prospective randomized trial, the immunorestorative potential of a combined therapy with the thymomimetic substance Thymopentin (TP-5; Timunoxrg, Cilag GMBH, Sulzbach, FRG) and the cyclooxygenase inhibitor indomethacin (Indo) in 60 patients (mean age, 63 ± 2 years) undergoing open heart surgery was studied. Perioperative immunologic screening was carried out on days —2, 3,1, 5, and 7 and included the in vivo delayed type hypersensitivity (DTH) skin response, phenotyping for peripheral blood mononuclear cell (PBMC)-specific and nonspecific induction of lymphoproliferative responses, in vitro interleukin-2 (IL-2) synthesis, as well as the serum concentration of D-erythro-Neopterin (NPT) and of gamma interferon (γ-IFN). The study protocol comprised three groups (n = 20): PA (Indo 150 mg administered intravenously on days 0 to 5), PB (TP-5 administered subcutaneously on days 0,2,4, and Indo), and PC (control). In contrast to PC, significant immunorestoration could be demonstrated in PB, as DTH scores on day 7, as well as proliferative responses in cell cultures were not depressed after operation (p <0.05). Cell-surface receptor expression for the CD3+, CD4+, and IL-2 receptor-positive (IL-2R+) lymphocyte subpopulations following surgery was reduced to 75% of baseline values in PC, while in PB, receptor protection for CD4+ and IL-2R+ subpopulations (more than 15% above baseline) was observed. Interleukin-2 synthesis (average baseline value, 0.7 ± 0.08 U/mL) in cell cultures of PC was massively suppressed, with lymphokine concentrations in the supernatants never more than 0.27 ± 0.05 U/mL. In PA cultures, IL-2 synthesis was impaired as well but not as precipitously as in PC. In contrast, in PB cultures, the average IL-2 production on consecutive postoperative days was never below baseline values. This study clearly demonstrates that the combined Indo/TP-5 therapy is superior to single Indo administration and can adequately preserve and/or restore intact MoST-cell interaction and thus appears to be a feasible approach to maintain normal host defense activity in traumatized individuals.Keywords
This publication has 21 references indexed in Scilit:
- Immunoprotective Effects of Cyclooxygenase Inhibition in Patients with Major Surgical Trauma1990
- The Immune-Enhancing Effect of Perioperative Thymopentin Administration in Elderly Patients Undergoing Major SurgeryArchives of Surgery, 1988
- Neopterin as a marker for activated cell-mediated immunity: Application in HIV infectionImmunology Today, 1988
- Alteration of Monocyte Function Following Major InjuryArchives of Surgery, 1988
- Prostaglandin E2 (PGE2)-dependent Suppression of Interleukin α (IL-2) Production in Patients with Major Trauma1987
- Patients at Risk for AIDS-Related Opportunistic InfectionsNew England Journal of Medicine, 1985
- Cardiopulmonary Bypass and Host Defense Functions in Human Beings: II. Lymphocyte FunctionThe Annals of Thoracic Surgery, 1985
- Inadequate Interleukin 2 ProductionAnnals of Surgery, 1984
- The immunomodulating effect of TP5 and indomethacin in burn-induced hypoimmunityJournal of Surgical Research, 1984
- Cell-Mediated Immunity Is Depressed Following Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1981